Status:
COMPLETED
Efficacy of Deep Transcranial Magnetic Stimulation in Patients With Opioid Use Disorder
Lead Sponsor:
Pamukkale University
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Deep TMS to the left dorsolateral prefrontal cortex intervention to reduce craving and recurrent opioid use among patients with opioid use disorder who are abstinent for at least one week.
Detailed Description
The participants will undergo baseline assessments, including rating scales and urine opioid metabolite tests. The participants will receive one of two treatments: High-frequency (10Hz, 3000 pulses pe...
Eligibility Criteria
Inclusion
- Age 18- 65
- Clinical diagnosis of opioid use disorder
Exclusion
- Currently pregnant or breastfeeding
- Mental retardation, bipolar disorder, any psychotic disorder
- Neurological diseases such as epilepsy, ischemic stroke, multiple sclerosis
- History of head trauma that resulted in loss of consciousness for ≥5 minutes and retrograde amnesia for ≥30 minutes (self-reported history)
- Any history of seizures other than febrile childhood seizures (self-reported history)
- Clinically significant hearing impairment
- Having any prosthesis, such as an implant and pacemaker.
- Illiteracy
Key Trial Info
Start Date :
October 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT06081985
Start Date
October 21 2021
End Date
April 1 2024
Last Update
November 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bengu Yucens
Denizli, Turkey (Türkiye), 20020